Overexpression of polo-like kinase 1 (PLK1) and chromosomal instability in bladder cancer

被引:78
|
作者
Yamamoto, Yoshiaki
Matsuyama, Hideyasu
Kawauchi, Shigeto
Matsumoto, Hiroaki
Nagao, Kazuhiro
Ohmi, Chietaka
Sakano, Shigeru
Furuya, Tomoko
Oga, Atsunori
Naito, Katsusuke
Sasaki, Kohsuke [1 ]
机构
[1] Yamaguchi Univ, Sch Med, Dept Pathol, Ube, Yamaguchi 7558505, Japan
[2] Yamaguchi Univ, Sch Med, Dept Urol, Ube, Yamaguchi 7558505, Japan
关键词
bladder cancer; centrosome amplification; chromosomal instability; polo-like kinase 1;
D O I
10.1159/000094416
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Polo-like kinase 1 (PLK1) participates in bipolar spindle formation and entry into mitosis. Chromosomal instability (CIN) is caused by abnormalities in spindle formation and chromosome segregation. In this study, we investigated the relationship of PLK1 overexpression to CIN, and compared the PLK1 status with clinicopathological parameters in 101 human urothelial carcinomas of the urinary bladder. Expression of PLK1 and the number of centrosomes were assessed by immunohistochemistry. Numerical aberrations of chromosomes 7, 9 and 17 spots that allowed estimation of CIN were evaluated by fluorescence in situ hybridization, and DNA ploidy was assessed by laser scanning cytometry. Cancers with a large intercellular variation in centromere copy number were defined as CIN cancers. Tumors with PLK1 overexpression were associated more frequently with CIN (p < 0.0001), DNA aneuploicly (p = 0.0007) and centrosome amplification (p = 0.0013) than those without. Overexpression of PLKI was significantly related to higher pathological grade (p = 0.0024), multiple tumors (p = 0.0241) and positive urine cytology (p = 0.0192). These data suggest that a high level expression of PLK1 confers tumor progression advantages to urothelial cancer cells, although other factors are also involved. Copyright (c) 2006 S. Karger AG, Basel
引用
收藏
页码:231 / 237
页数:7
相关论文
共 50 条
  • [31] Expression of polo-like kinase (PLK1) in non-Hodgkin's lymphomas
    Mito, K
    Kashima, K
    Kikuchi, H
    Daa, T
    Nakayama, I
    Yokoyama, S
    LEUKEMIA & LYMPHOMA, 2005, 46 (02) : 225 - 231
  • [32] Polo-like kinase (Plk) 1 as a target for prostate cancer management
    Reagan-Shaw, S
    Ahmad, N
    IUBMB LIFE, 2005, 57 (10) : 677 - 682
  • [33] Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate
    Nakajima, H
    Toyoshima-Morimoto, F
    Taniguchi, E
    Nishida, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (28) : 25277 - 25280
  • [34] Polo-like kinase 1 (Plk1) as a predictive marker for treatment response to neoadjuvant radiochemotherapy in patients with rectal cancer
    Capalbo, G.
    Bashary, R.
    Roedel, F.
    Spaekuch, B.
    Roedel, C.
    Strebhardt, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 29 - 29
  • [35] Targeting of the Polo-like kinase 1 (PLK1) to improve the efficiency of Olaparib in BRCA mutated epithelial ovarian cancer
    Gasimli, Khayal
    Rad, Morva Tahmasbi
    Raab, Monika
    Becker, Sven
    Kurunci-Csacsko, Elisabeth
    Strebhardt, Klaus
    Sanhaji, Mourad
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 118 - 119
  • [36] MOLECULAR TARGETING OF POLO-LIKE KINASE 1 (PLK1) ELIMINATES MEDULLOBLASTOMA BRAIN TUMOUR CELLS
    Lee, Cathy
    Fotovati, Abbas
    Triscott, Joanna
    Dunn, Sandra
    NEURO-ONCOLOGY, 2012, 14 : 96 - 96
  • [37] Polo-like kinase 1 (PLK1) is a novel CARD14-binding protein in keratinocytes
    Iliaki, Styliani
    Kreike, Marja
    Moreno, Natalia Ferreras
    De Meyer, Femke
    Aidarova, Aigerim
    Braun, Harald
    Libert, Claude
    Afonina, Inna S.
    Beyaert, Rudi
    BIOCHEMICAL PHARMACOLOGY, 2024, 228
  • [38] Inhibition of polo-like kinase 1 (PLK1) in endocrine-resistant ER plus breast cancer.
    Jansen, Valerie Malyvanh
    Bhola, Neil E.
    Bafna, Sangeeta
    Giltnane, Jennifer Margaret
    Balko, Justin M.
    Dugger, Teresa C.
    Arteaga, Carlos L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination
    Biswas, Ayan
    Zhou, Dawei
    Fiches, Guillaume N.
    Wu, Zhenyu
    Liu, Xuefeng
    Ma, Qin
    Zhao, Weiqiang
    Zhu, Jian
    Santoso, Netty G.
    PLOS PATHOGENS, 2021, 17 (07)
  • [40] Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma
    Kanaji, Shingo
    Saito, Hiroaki
    Tsujitani, Shunichi
    Matsumoto, Sachiko
    Tatebe, Shigeru
    Kondo, Akira
    Ozaki, Mitsuhiko
    Ito, Hisao
    Ikeguchi, Masahide
    ONCOLOGY, 2006, 70 (02) : 126 - 133